According to current estimates, some 10,000 people have been killed in the Philippines by super-typhoon Haiyan, 620,000 displaced, and over 9 million affected. Emergency relief and reconstruction assistance will be required on a large scale and for an extended period – perhaps more frequently in future years as climate change leads to an increase in extreme weather events.
CGD Policy Blogs
Low-cost private schools are popping up rapidly in many parts of the developing world, especially India where even in rural areas 28% of students attend private schools. Should governments be supporting these schools as a cheap way to boost learning for the poor? Or is privatization reducing equity and undermining public institutions? A year ago I participated in a somewhat heated online debate on this topic, see here and here.
This is a joint post with Yuna Sakuma.
The majority of the world’s sick live in middle-income countries (MIC) – mainly Pakistan, India, Nigeria, China and Indonesia (or PINCI), according to new data from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Sound familiar? Andy Sumner, Denizhan Duran, and I came to the same conclusion in a 2011 paper, but we used 2004 disease burden data, which didn’t provide an up-to-date view of reality. So I was pleased to see that our findings still hold based on IHME’s 2010 Global Burden of Disease (GBD) estimates.
This post originally appeared in the Business Standard.
This United Progressive Alliance (UPA) government is heading into the tenth and possibly last year of office, a tenure whose crowning achievement might well be the Food Security Bill. One may fault this government for incompetence, corruption, and delayed action but it cannot be faulted for lacking a vision. There has been an overarching idea that underlies many of its economic policies: namely, that the poor and underprivileged in society must be empowered by conferring them with new rights - to work, education, food, and presumably, all basic needs.
Earlier this year, Nancy Birdsall and I laid out why India’s new cash transfer program is superior to current in-kind subsidy programs on which the government spends $26 billion a year with no discernible impact on poverty. While not a panacea, the new program has a lot going for it – cash transfers have been shown to work for poverty reduction in many settings, the program uses a biometrics-based system to identify beneficiaries and process payments, and the country has experience in implementing similar programs like the JSY – a cash transfer conditional on a facility birth.
This post originally appeared on the Peterson Institute for International Economics blog.
On April 1, the Indian Supreme Court rejected the attempt by Novartis, the Swiss pharmaceutical company, to patent a new version of the leukemia drug Glivec. The latest verdict follows previous rulings that granted compulsory licenses to an Indian generic drug manufacturer for a kidney cancer drug (Nexavar) patented by Bayer. Five important questions are raised by these rulings.
My recent wonky indulgence has been exploring the visualization tool of the Global Burden of Disease Study (GBD), which produces stunning graphs that display a snapshot of our planet’s disease burden across 5-year intervals from 1990 to 2010. The global and regional results of the study were launched in December 2012 in a special issue of The Lancet, and there are several country-specific papers expected this year.
Last week, the Government of India held a star-studded National Summit on child survival, “co-convened”* with USAID and UNICEF. The high-profile meeting featured politicians (the Minister of Health & Family Welfare, the US Ambassador to India), heavy-hitters in global child health (Bob Black, Zulfiqar Bhutta, Mickey Chopra, Geeta Rao Gupta) along with some Indian stars of child health (Vinod Paul, Abhay Bang, Yogesh Jain), and even a Bollywood actress/“child rights activist” Nandana Sen (daughter of Nobel Laureate and Professor Amartya Sen), to name a few.